About one in five people who have stopped smoking for more than a year in England currently vape, equivalent to 2.2 million people, according to a new study led by UCL (University College London) researchers.
ALX cuts two anti-CD47 programs just weeks after Gilead stopped a pivotal study of its own candidate
ALX Oncology is cutting two studies of its anti-CD47 drug evorpacept after it failed to show substantial efficacy. In its second-quarter report Thursday afternoon, ALX
August 12, 2023